2023 Vol. 14, No. 3
column
- Editorial
- Specialist Forum
- Guideline and Consensus
- Guideline Interpretation
- Original Contributions
- Reviews
- Complicated and Rare Disease
- Clinical Research and Evidence Based Medicine
- Clinical Practice Guidelines
- Clinical Case Analysis
- Breast Cancer
- Medical Supports to Tibet & Xinjiang
- Drug Therapy for Tumors
- Teaching and Research
Display Method:
2023, 14(3): 478-483.
doi: 10.12290/xhyxzz.2022-0675
Abstract:
2023, 14(3): 484-493.
doi: 10.12290/xhyxzz.2022-0699
Abstract:
2023, 14(3): 494-503.
doi: 10.12290/xhyxzz.2023-0137
Abstract:
2023, 14(3): 520-527.
doi: 10.12290/xhyxzz.2022-0730
Abstract:
2023, 14(3): 536-542.
doi: 10.12290/xhyxzz.2022-0623
Abstract:
2023, 14(3): 543-552.
doi: 10.12290/xhyxzz.2022-0183
Abstract:
Abstract:
2023, 14(3): 559-565.
doi: 10.12290/xhyxzz.2022-0654
Abstract:
2023, 14(3): 566-574.
doi: 10.12290/xhyxzz.2022-0538
Abstract:
2023, 14(3): 575-580.
doi: 10.12290/xhyxzz.2022-0155
Abstract:
2023, 14(3): 581-585.
doi: 10.12290/xhyxzz.2022-0593
Abstract:
2023, 14(3): 586-590.
doi: 10.12290/xhyxzz.2022-0279
Abstract:
2023, 14(3): 591-597.
doi: 10.12290/xhyxzz.2022-0486
Abstract:
2023, 14(3): 598-602.
doi: 10.12290/xhyxzz.2022-0647
Abstract:
2023, 14(3): 611-616.
doi: 10.12290/xhyxzz.2023-0091
Abstract:
2023, 14(3): 617-620.
doi: 10.12290/xhyxzz.2022-0240
Abstract:
Abstract:
2023, 14(3): 633-637.
doi: 10.12290/xhyxzz.2022-0434
Abstract:
2023, 14(3): 646-651.
doi: 10.12290/xhyxzz.2022-0610
Abstract:
2023, 14(3): 652-659.
doi: 10.12290/xhyxzz.2022-0617
Abstract:
2023, 14(3): 660-664.
doi: 10.12290/xhyxzz.2022-0676
Abstract: